ロード中...
Impact of the US Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture
The U.S. FDA issued several announcements related to potential risk of bisphosphonates including osteonecrosis of the jaw (2005), atrial fibrillation (2007) and atypical femur fracture (2010). We aimed to evaluate the impact of three FDA drug safety announcements on the use of bisphosphonates in pat...
保存先:
| 出版年: | J Bone Miner Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5040596/ https://ncbi.nlm.nih.gov/pubmed/26969902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2832 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|